These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12605547)

  • 21. DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil.
    Dufloth RM; Costa S; Schmitt F; Zeferino LC
    Genet Mol Res; 2005 Dec; 4(4):771-82. PubMed ID: 16475125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin receptor 1B (MTNR1B) gene polymorphism is associated with the occurrence of adolescent idiopathic scoliosis.
    Qiu XS; Tang NL; Yeung HY; Lee KM; Hung VW; Ng BK; Ma SL; Kwok RH; Qin L; Qiu Y; Cheng JC
    Spine (Phila Pa 1976); 2007 Jul; 32(16):1748-53. PubMed ID: 17632395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3.
    Bertinetto FE; Calafell F; Roggero S; Chidichimo R; Garino E; Marcuccio C; Coppo R; Scolari F; Frascá GM; Savoldi S; Schena FP; Amoroso A;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2328-37. PubMed ID: 22131235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [From genome-wide association studies (gwas) to genome-wide polygenic scores (GPS)].
    Jordan B
    Med Sci (Paris); 2018 Dec; 34(12):1116-1122. PubMed ID: 30623770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skilled use of DNA polymorphisms as a tool for polygenic cancers.
    Hemminki K; Shields PG
    Carcinogenesis; 2002 Mar; 23(3):379-80. PubMed ID: 11895851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphism and clinical outcome: identification of individuals at risk of a poor clinical outcome.
    Strange RC; Alldersea J; Hoban PR; Fryer AA; Matthias C; Jahnke V; Jones PW
    Allergy; 2000; 55 Suppl 61():10-4. PubMed ID: 10919499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing candidate gene and genome-wide case-control association studies.
    Zondervan KT; Cardon LR
    Nat Protoc; 2007; 2(10):2492-501. PubMed ID: 17947991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practicalities of genetic studies in human stroke.
    Hassan A; Markus HS
    Methods Mol Med; 2005; 104():223-40. PubMed ID: 15454670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms of infectious diseases in case-control studies.
    Pacheco AG; Moraes MO
    Dis Markers; 2009; 27(3):173-86. PubMed ID: 19893211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicological considerations in the application and interpretation of susceptibility biomarkers in epidemiological studies.
    De Roos AJ; Smith MT; Chanock S; Rothman N
    IARC Sci Publ; 2004; (157):105-25. PubMed ID: 15055293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incomplete coverage of candidate genes: a poorly considered bias.
    Drago A; De Ronchi D; Serretti A
    Curr Genomics; 2007 Nov; 8(7):476-83. PubMed ID: 19412419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
    Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-institutional Study of Outcomes After Pediatric Heart Transplantation: Candidate Gene Polymorphism Analysis of ABCC2.
    Burckart GJ; Figg WD; Brooks MM; Green DJ; Troutman SM; Ferrell R; Chinnock R; Canter C; Addonizio L; Bernstein D; Kirklin JK; Naftel D; Price DK; Sissung TM; Girnita DM; Zeevi A; Webber SA
    J Pediatr Pharmacol Ther; 2014 Jan; 19(1):16-24. PubMed ID: 24782687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.
    Andersen V; Christensen J; Ernst A; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
    World J Gastroenterol; 2011 Jan; 17(2):197-206. PubMed ID: 21245992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms associated with acute lung injury.
    Reddy AJ; Kleeberger SR
    Pharmacogenomics; 2009 Sep; 10(9):1527-39. PubMed ID: 19761373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study.
    Perez de los Cobos J; Baiget M; Trujols J; Sinol N; Volpini V; Banuls E; Calafell F; Luquero E; del Rio E; Alvarez E
    Behav Brain Funct; 2007 Jun; 3():25. PubMed ID: 17543096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human pharmacogenomic variations and their implications for antifungal efficacy.
    Meletiadis J; Chanock S; Walsh TJ
    Clin Microbiol Rev; 2006 Oct; 19(4):763-87. PubMed ID: 17041143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candidate gene case-control studies.
    Daly AK
    Pharmacogenomics; 2003 Mar; 4(2):127-39. PubMed ID: 12605547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candidate gene case-control association studies: advantages and potential pitfalls.
    Daly AK; Day CP
    Br J Clin Pharmacol; 2001 Nov; 52(5):489-99. PubMed ID: 11736857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.